Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 2

Sponsor

Cancer Type

CNS 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 20Leukemia 11Lymphoma 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Prostatic Neoplasms 6Lymphoma, Follicular 6Ovarian Neoplasms 5Neuroblastoma 5Kidney Neoplasms 5Carcinoma, Ovarian Epithelial 5Wilms Tumor 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Melanoma 4Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Acute 4Congenital Abnormalities 4Colorectal Neoplasms 4Colonic Neoplasms 4Central Nervous System Neoplasms 4Adenocarcinoma of Lung 4Testicular Neoplasms 3Myeloproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

Surveys and Questionnaires 15Radiosurgery 14Magnetic Resonance Imaging 11Magnetic Resonance Spectroscopy 10Neuropsychological Tests 8Radiotherapy 7Radiation 4Blood Specimen Collection 4Patient Reported Outcome Measures 3sacituzumab govitecan 2Trastuzumab 2Surgical Procedures, Operative 2Quality of Life 2Physical Examination 2Phlebotomy 2Perfusion Magnetic Resonance Imaging 2Lead 2Lapatinib 2Interviews as Topic 2Immunotherapy 2Drug Therapy 2Data Collection 2Brain Mapping 2Bevacizumab 2Amplified Fragment Length Polymorphism Analysis 2Aminolevulinic Acid 2trastuzumab deruxtecan 1pembrolizumab 1osimertinib 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Brain Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01009307 2019-07-22

Study of Blood and Cheek Cell Samples From Patients With Glioma

University of California, San Francisco

Completed
1,709 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

NCT00757614 2013-08-26

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

National Cancer Institute (NCI)

Unknown
14,000 enrolled
CNSDermatologicGastrointestinalGenitourinaryLymphoidOther hematologic neoplasm

Uveal Melanoma, Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Renal Cell, Craniopharyngioma, Esophageal Neoplasms, Hodgkin Disease, Kidney Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Meningeal Neoplasms, Neoplasms, Germ Cell and Embryonal, Pancreatic Neoplasms, Pinealoma, Lymphoma, T-Cell, Cutaneous, Lymphoma, AIDS-Related, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Nephroma, Mesoblastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡